Brief: Abionyx Pharma Announces H1 Sales Of EUR 2.1 Mln

Abionyx Pharma SA

17/08/2023 17:26

Aug 17 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX PHARMA PROVIDES AN UPDATE ON ITS BUSINESS AND CASH
POSITION FOR THE FIRST HALF OF 2023
    * CASH OF EUR 1.9 MILLION (EXCLUDING RESEARCH TAX CREDIT) AS
OF
JUNE 30, 2023
    * CONSOLIDATED HALF-YEAR SALES OF EUR 2.1 MILLION

Source text for Eikon:  ID:nBw7kZbWXa 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))